ObsEva SA
Overview
ObsEva SA is a biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics to improve women's reproductive health. The company targets a range of conditions such as endometriosis, uterine fibroids, and preterm labor.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to ObsEva SA in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
ObsEva USA, Inc.
Switzerland
Contraceptive Research Group Ltd.
United Kingdom
Fertility Research Institute
USA
Reproductive Health Research Institute
Chile
The Population Council in partnership with TherapeuticsMD
United States
Women's Health Research Institute
United States
Ferring Pharmaceuticals
Switzerland
Ferring Pharmaceuticals A/S
Switzerland
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.